Harrow Health, Inc. (HROW) vs Tyra Biosciences, Inc. (TYRA)

A side-by-side comparison of Harrow Health, Inc. and Tyra Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — HROW vs TYRA

growth of $100 · dividends reinvested · last 5y
HROW +237.9% (+27.6%/yr)TYRA -19.5% (-4.2%/yr)HROW compounded faster over this window
0200400600Start $10020222023202420252026$338$81
HROW TYRA

HROW vs TYRA: by the numbers

  • •TYRA is the larger company ($1.21B vs $1.13B market cap).
  • •Both run net losses; TYRA's is the smaller (0.00% vs -13.51% net margin).

Metrics side by side

Valuation

MetricHROWTYRA
P/S ratio4.10N/A
P/B ratio74.433.41
FCF yield0.47%N/A

Profitability

MetricHROWTYRA
Gross margin73.28%0.00%
Operating margin14.18%0.00%
Net margin-13.51%0.00%
ROE-244.91%-42.01%
ROIC1.81%-44.73%

Growth (annualized)

MetricHROWTYRA
Revenue CAGR (5Y)34.52%N/A
Total return CAGR (5Y)27.66%9.23%

Frequently asked

How have HROW and TYRA total returns compared?
Over the past 5 years, HROW delivered 27.66% and TYRA delivered 9.23% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.